Proteins and Peptides

31 Jan 2007 Gloucester Pharmaceuticals Receives Special Protocol Assessment for Pivotal Phase II Trial of Romidepsin in Patients with Peripheral T-Cell Lymphoma
31 Jan 2007 OctoPlus initiates Locteron Phase II clinical study in chronic hepatitis C
31 Jan 2007 ZymoGenetics Begins Clinical Trial for PEG-Interferon lambda as Potential Treatment for Viral Infection
31 Jan 2007 Alfacell Corporation Granted U.S. Orphan Drug Designation for ONCONASE(R) for Treatment of Malignant Mesothelioma
30 Jan 2007 ReceptoPharm Begins Phase IIb Human Clinical Trial for the Treatment of Adrenomyeloneuropathy
27 Jan 2007 Largest-ever stroke registry confirms safety of Actilyse(R) thrombolysis treatment for acute ischaemic stroke
26 Jan 2007 Bayer discontinues Trasylol(R) clinical trial program in non-CABG indications
26 Jan 2007 Spectrum Pharmaceuticals Initiates Phase 2b Trial for Ozarelix in Patients with Benign Prostate Hypertrophy
26 Jan 2007 Altea Therapeutics Announces Positive Clinical Results for its Basal Insulin Transdermal Patch
26 Jan 2007 BioMimetic Therapeutics Reports Positive Clinical Results Using GEM OS®1 to Treat Distal Radius Fractures
25 Jan 2007 Scil Technology Completes Patient Enrollment in European Phase II Sinus Lift Study
25 Jan 2007 Molecular Insight Pharmaceuticals, Inc. Acquires Clinical Stage, Targeted Radiotherapeutic Candidate Onalta(TM) (Formerly OctreoTher(TM))
23 Jan 2007 Halozyme Therapeutics Releases Results of Enhanze Technology Clinical Trial to Improve the Subcutaneous Absorption of a Large Protein Molecule Therapeutic
23 Jan 2007 Discovery Labs and FDA Reach Clarity On Path Towards Surfaxin RDS Approval
23 Jan 2007 MIGENIX Announces Initiation of Rosacea Phase II Clinical Study by Partner, Cutanea Life Sciences
23 Jan 2007 Artielle ImmunoTherapeutics, Inc., and QSV Biologics, Ltd. Sign Contract for cGMP Manufacture of RTL 1000 for Multiple Sclerosis
19 Jan 2007 Protox Reports Promising Interim Results From Prostate Cancer Study
19 Jan 2007 CSC'S DVC And Baxter Begin Phase 1 Clinical Trial For Chemical Defense Product
18 Jan 2007 MGI PHARMA Announces Publication of Phase 3 Data for Saforis(TM) (glutamine) Powder in UpTec(TM) for Oral Suspension in Cancer
18 Jan 2007 Lev Pharmaceuticals, Inc. Announces Final Patient Treated In Pivotal Phase III HAE Trial
17 Jan 2007 Oxford Biomedica Announces Publication Of Avian Transgenic Results In Leading U.S. Scientific Journal
17 Jan 2007 Largest-ever Fabry study shows earlier treatment with (Pr)Fabrazyme(R) 1 mg/kg means less damage from rare Fabry disease
17 Jan 2007 Pharming Receives European Orphan Drug Designation
17 Jan 2007 Neose Receives Approval to Commence Phase II Clinical Trial For NE-180
16 Jan 2007 Genzyme Announces Publication of Study Showing Impact of Cerezyme on Bone Health for Patients with Type 1 Gaucher Disease

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top